Inivata Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Inivata Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3307
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inivata Ltd (Inivata) is a cancer genomics company. The company offers products such as invisionfirst- lungin and visionseq. Its InVisionFirst offers advanced sequencing technology to detect single nucleotide variants copy number variants, insertions and deletions and structural variants in selected genes from dna isolated from plasma samples from patients with non-small cell lung cancer. Inivata works with industry and academic researchers to develop new clinical applications for liquid biopsy and ctdna analysis. The company offers Liquid biopsies to clinical outcomes. It operates in Canada and the US. Inivata is headquartered in Cambridge, the UK.

Inivata Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Inivata Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Inivata Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Inivata Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inivata Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Inivata Raises USD6.5 Million in Venture Financing 11
Partnerships 12
Genomics England, Inivata and Thermo Fisher Enter into Agreement 12
Addario Lung Cancer Enters into Agreement with Inivata 13
Inivata Ltd – Key Competitors 14
Inivata Ltd – Key Employees 15
Inivata Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
May 08, 2018: Michael Stocum to step down as Inivata CEO 17
Oct 26, 2017: Inivata Announces World-Leading SAB 18
Sep 08, 2017: Inivata Announces Appointment of Dr Jamie Platt as Chief Operations Officer 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Inivata Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Inivata Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Inivata Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Inivata Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Inivata Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inivata Raises USD6.5 Million in Venture Financing 11
Genomics England, Inivata and Thermo Fisher Enter into Agreement 12
Addario Lung Cancer Enters into Agreement with Inivata 13
Inivata Ltd, Key Competitors 14
Inivata Ltd, Key Employees 15
Inivata Ltd, Subsidiaries 16

List of Figures
Inivata Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Inivata Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Inivata Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Inivata Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Inivata Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pepco Holdings LLC-エネルギー分野:企業M&A・提携分析
    Summary Pepco Holdings, LLC (Pepco Holdings), formerly Pepco Holdings, Inc., a subsidiary of Exelon Corporation, is a utility services holding company that transmits, distributes and supplies electricity through its subsidiaries. It also distributes and supplies natural gas. The company, through its …
  • Circle Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Circle Pharma Inc (Circle Pharma) is a developer of cell permeable macrocyclic peptide therapies by combining structure-based computational design and synthetic chemistry. The company’s automated chemistry synthesis enable to assess, in parallel, multiple design hypotheses for given target, …
  • Formycon AG (FYB):企業の財務・戦略的SWOT分析
    Summary Formycon AG (Formycon) formerly Nanohale AG is a biopharmaceutical company that develops biosimilar drugs candidates. The company offers biopharmaceutical imitation products for global recovery. It provides four biosimilar products in pre-clinical and clinical testing phases. Formycon’s pipe …
  • Medicom Innovation Partner as-医療機器分野:企業M&A・提携分析
    Summary Medicom Innovation Partner a/s (Medicom), formerly Bang & Olufsen Medicom, a subsidiary of Phillips-Medisize Corp, is a medical device company that develops electronic-based drug delivery and connected health systems. The company offers services such as device strategy and direction, device …
  • Beckman Research Institute Of The City Of Hope-製薬・医療分野:企業M&A・提携分析
    Summary Beckman Research Institute of The City Of Hope (Beckman Research), a subsidiary of City of Hope is a biomedical research institute that provides a range of healthcare services. The institute provides treatment that includes diabetes progression and treatment, immunology and imaging, mechanis …
  • Nissin Electric Co Ltd (6641):企業の財務・戦略的SWOT分析
    Nissin Electric Co Ltd (6641) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • SNC-Lavalin Group Inc (SNC)-石油・ガス分野:企業M&A・提携分析
    Summary SNC-Lavalin Group Inc. (SNC) is global provider of engineering and construction services. It offers a range of engineering, procurement, construction, project management services to various industries, including oil and gas, mining and metallurgy, infrastructure and power. In addition, the c …
  • China Resources Wandong Medical Equipment Co Ltd (600055):医療機器:M&Aディール及び事業提携情報
    Summary China Resources Wandong Medical Equipment Co Ltd (Wandong Medical Equipment), formerly Beijing Wandong Medical Equipment Co Ltd, a subsidiary of Beijing Pharmaceutical Group Co Ltd, is a medical device company that develops and markets medical devices and equipment. The company’s products in …
  • BioTime Inc (BTX):企業の財務・戦略的SWOT分析
    BioTime Inc (BTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Capri Holdings Ltd:企業の戦略・SWOT・財務分析
    Capri Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Capri Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • AAC Technologies Holdings Inc. (2018):企業の財務・戦略的SWOT分析
    AAC Technologies Holdings Inc. (2018) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Rutherford Electric Membership Corp:企業の戦略的SWOT分析
    Rutherford Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Fiesta Mart LLC:企業の戦略的SWOT分析
    Fiesta Mart LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • UniQure NV (QURE):企業の財務・戦略的SWOT分析
    UniQure NV (QURE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Geron Corp (GERN):医療機器:M&Aディール及び事業提携情報
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • The Bank of Yokohama Ltd:企業の戦略・SWOT・財務分析
    The Bank of Yokohama Ltd - Strategy, SWOT and Corporate Finance Report Summary The Bank of Yokohama Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CivaTech Oncology Inc:医療機器:M&Aディール及び事業提携情報
    Summary CivaTech Oncology Inc (CivaTech) is a medical device company that provides radiation therapy solutions. The company develops polymer based low dose rate (LDR) brachytherapy devices for the treatment of cancer. Its product portfolio includes CivaString, a radiation therapy device to treat sol …
  • Senomyx Inc (SNMX):企業の財務・戦略的SWOT分析
    Summary Senomyx Inc (Senomyx) focuses on the discovery, development and commercialization of novel flavor ingredients and natural high intensity sweeteners (HIS) to packaged food, beverage and ingredient supply industries. The company discovers and develops novel flavor ingredients and natural HIS t …
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務情報
    Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆